About

FyMed, Inc. is a biopharmaceutical company with a growing portfolio of novel and improved pharmaceuticals developed through ultra-sensitive next generation targeted companion diagnostics and prognostics. Leading innovations in personalized medicine has enabled FyMed to effectively balance technological innovation with scientific discovery, creating tools that can productively integrate with drug development and capitalize on key market deficiencies.